Canada Pension Plan Investment Board’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-444,900
Closed -$15.8M 1425
2025
Q2
$15.8M Buy
+444,900
New +$14.4M 0.01% 511
2024
Q1
Sell
-457,490
Closed -$27.5M 1216
2023
Q4
$27.5M Hold
457,490
0.03% 348
2023
Q3
$30.7M Sell
457,490
-9,100
-2% -$632K 0.04% 314
2023
Q2
$32.2M Buy
466,590
+335,600
+256% +$21.9M 0.05% 284
2023
Q1
$6.32M Sell
130,990
-281,800
-68% -$13.8M 0.01% 538
2022
Q4
$20.6M Buy
412,790
+1,400
+0.3% +$67.8K 0.04% 321
2022
Q3
$16.8M Buy
411,390
+308,800
+301% +$14.5M 0.03% 366
2022
Q2
$5.64M Sell
102,590
-154,710
-60% -$6.53M 0.01% 515
2022
Q1
$9.35M Buy
257,300
+40,500
+19% +$1.6M 0.01% 509
2021
Q4
$10.1M Buy
216,800
+188,200
+658% +$9.55M 0.01% 575
2021
Q3
$1.45M Buy
+28,600
New +$1.19M ﹤0.01% 910
2021
Q2
Sell
-125,900
Closed -$3.65M 1274
2021
Q1
$3.65M Buy
+125,900
New +$3.43M ﹤0.01% 702

Other funds holding LEGN

Canada Pension Plan Investment Board's LEGN Position: Q3 2025 in Review

Canada Pension Plan Investment Board sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 444,900 shares — an estimated $15.8M sold.

Canada Pension Plan Investment Board first reported a position in LEGN in Q1 2021 and held it in 12 quarters. The position peaked at $32.2M in Q2 2023. 200 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • Canada Pension Plan Investment Board reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 444,900 Legend Biotech shares in Q3 2025, an estimated $15.8M.
  • Canada Pension Plan Investment Board first reported a position in Legend Biotech in Q1 2021 and held it in 12 quarters.
  • Canada Pension Plan Investment Board's Legend Biotech position peaked at $32.2M in Q2 2023.
  • 200 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2025, filed 13 Nov 2025.